NCT02151474View on ClinicalTrials.gov

INCB047986 in Rheumatoid Arthritis

PHASE2TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Rheumatoid Arthritis

Interventions

DRUG

INCB047986

DRUG

Placebo

Trial Locations (9)

Unknown

Orange

DeBary

Palm Harbor

Tampa

Frederick

Charlotte

Oklahoma City

Austin

The Woodlands

Sponsors

Lead Sponsor

Incyte Corporation

All Listed Sponsors

lead

Incyte Corporation

INDUSTRY

NCT02151474 - INCB047986 in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter